+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis



Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis



Journal of Pediatrics 113(5): 901-907



We compared nalidixic acid, 55 mg/kg/day, with ampicillin, 100 mg/kg/day, both given orally for 5 days, in the treatment of children with dysentery caused by shigellosis. All patients entered into the study had illness of less than 72 hours' duration and no prior allopathic drug therapy. Treatment was randomized and administered in double-blind fashion. Patients initially treated with ampicillin who were infected with a Shigella strain resistant to ampicillin were considered as a separate group (ampicillin-R). All isolates were susceptible to nalidixic acid. Similar percentages of patients treated with nalidixic acid (26/32, 81%) and with ampicillin (17/22, 77%) were clinically cured by the end of therapy; the rate in ampicillin-R (3/14, 21%) patients was significantly lower (p less than 0.001). Stool frequency in patients treated with nalidixic acid was significantly less than for ampicillin-treated or ampicillin-R patients during the final 3 study days. All patients treated with nalidixic acid and ampicillin had Shigella eradicated from their stool by day 3, compared with 77% (10/13) of ampicillin-R patients (p less than 0.05, ampicillin-R vs nalidixic acid or ampicillin). We conclude that nalidixic acid is an effective alternative to ampicillin in the treatment of shigellosis caused by nalidixic acid-susceptible strains.

(PDF emailed within 0-6 h: $19.90)

Accession: 041793525

Download citation: RISBibTeXText

PMID: 3054035

DOI: 10.1016/s0022-3476(88)80029-5


Related references

Green banana reduces clinical severity and colonic inflammation in acute childhood shigellosis a double blind, randomized, controlled trial. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No 480, 2003

Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children. Journal of Tropical Pediatrics 40(6): 320-325, 1994

Azithromycin as an alternative to nalidixic acid in the therapy of childhood shigellosis. Pediatric Infectious Disease Journal 23(4): 367-368, 2004

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. Bmc Infectious Diseases 12: 111, 2013

Green Banana Reduces Clinical Severity of Childhood Shigellosis: A Double-Blind, Randomized, Controlled Clinical Trial. Yearbook of Pediatrics 2011: 291-293, 2011

Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. Pediatric Infectious Disease Journal 28(5): 420-425, 2009

A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis. Journal Of Pediatrics. 123(5): 817-821, 1993

Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Annals of Internal Medicine 126(9): 697-703, 1997

Double-blind, randomized clinical trial for safety and efficacy of norfloxacin or shigellosis in children. Acta Paediatrica 86(3): 319-320, 1997

Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. Journal of Infectious Diseases 162(3): 711-716, 1990

Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial. Acta Paediatrica 90(12): 1373-1378, 2002

Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial. Journal of Diarrhoeal Diseases Research 10(3): 146-150, 1992

Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it. Journal of Tropical Medicine and Hygiene 98(2): 121-125, 1995

Nalidixic acid for shigellosis. Lancet 2(8358): 1091, 1983

Single dose vitamin A treatment in acute shigellosis in Bangladeshi children: Randomised double blind controlled trial. BMJ 316(7129): 422-426, Feb 7, 1998